EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Coats disease: A narrative review of clinical spectrum, imaging features, and contemporary management

Fawaz Almutairi iD, Ali Esmaeil, Nouf Al-Farsi, Aseel AlKandari, Alaa AlAli

Science Progress · 2026

DOI: 10.1177/00368504261484841 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Progress, 2026. Verfasst von Fawaz Almutairi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kuwait Institute for Medical Specializations, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Retinal Telangiectasis. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coats disease is a rare idiopathic retinal vascular disorder characterized by telangiectatic and aneurysmal retinal vessels, intraretinal and subretinal lipid exudation, and variable progression to exudative retinal detachment, secondary glaucoma, and severe visual loss. This narrative review summarizes the clinical spectrum, diagnostic evaluation, imaging features, and contemporary management of Coats disease, with emphasis on areas of diagnostic uncertainty and treatment controversy. The disease most commonly affects young males and is classically unilateral; however, rare bilateral presentations and Leber miliary aneurysms should be recognized within the broader spectrum of idiopathic retinal telangiectatic disease. Modern multimodal imaging, including wide-field photography, fluorescein angiography, optical coherence tomography, and optical coherence tomography angiography, has improved detection of peripheral nonperfusion, macular edema, subfoveal lipid, photoreceptor damage, and vascular abnormalities with prognostic implications. Management remains stage-dependent. Laser photocoagulation and cryotherapy remain the foundation of treatment, while anti-vascular endothelial growth factor therapy, corticosteroids, photodynamic therapy, and surgery have selective roles as adjunctive or advanced-stage interventions. The evidence base is limited by heterogeneous retrospective series, small case reports, and scarce comparative prospective data. Further multicenter studies are needed to define treatment algorithms, imaging biomarkers, long-term safety, and functional outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal TelangiectasisHumansTomography, Optical CoherenceFluorescein AngiographyLaser CoagulationCryotherapyRetinal VesselsMaleMultimodal Imaging

Stichwörter der Autor:innen

anti-VEGFcoats diseasecryotherapyexudative retinopathylaser photocoagulationleber miliary aneurysmsoptical coherence tomography angiographyretinal telangiectasia

Autor:innen und Institutionen

  • Kuwait Institute for Medical Specializations, Kuwait City, Kuwait.
  • Al Bahar Eye Centre, Ibn Sina Hospital, Kuwait City, Kuwait.
  • Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman.
  • Ophthalmology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.

ORCID-Profile: Fawaz Almutairi

Zitieren

APA

Almutairi, F., Esmaeil, A., Al-Farsi, N., AlKandari, A., & AlAli, A. (2026). Coats disease: A narrative review of clinical spectrum, imaging features, and contemporary management. Science Progress. https://doi.org/10.1177/00368504261484841

Vancouver

Almutairi F, Esmaeil A, Al-Farsi N, AlKandari A, AlAli A. Coats disease: A narrative review of clinical spectrum, imaging features, and contemporary management. Science Progress. 2026. doi:10.1177/00368504261484841

BibTeX
@article{Almutairi2026,
  author = {Almutairi, Fawaz and Esmaeil, Ali and Al-Farsi, Nouf and AlKandari, Aseel and AlAli, Alaa},
  title = {Coats disease: A narrative review of clinical spectrum, imaging features, and contemporary management},
  journal = {Science Progress},
  year = {2026},
  doi = {10.1177/00368504261484841}
}
Kostenlos starten →